Key statistics
On Monday, Zymeworks Inc (ZYME:NSQ) closed at 23.31, -18.18% below its 52-week high of 28.49, set on Nov 26, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 22.55 |
|---|---|
| High | 23.66 |
| Low | 22.26 |
| Bid | -- |
| Offer | -- |
| Previous close | 23.29 |
| Average volume | 579.72k |
|---|---|
| Shares outstanding | 74.84m |
| Free float | 70.21m |
| P/E (TTM) | -- |
| Market cap | 1.74bn USD |
| EPS (TTM) | -0.8448 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing
- Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
- Zymeworks To Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on March 2, 2026
- Zymeworks Announces Participation in Upcoming Investor Conferences
- Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy
- Zymeworks Outlines Strategic Priorities and Outlook for 2026
- Ziihera® (zanidatamab-hrii) Combinations Achieve Unprecedented Results in First-Line HER2+ Locally Advanced or Metastatic GEA including more than Two Years Median Overall Survival Benefit
- Zymeworks Announces Participation in Upcoming Conferences
- Zymeworks Announces Participation in Upcoming Investor Conferences
- Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
More ▼
